We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+20.86%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$710M
AUM Growth
+$164M
Cap. Flow
+$64.1M
Cap. Flow %
9.04%
Top 10 Hldgs %
36.24%
Holding
113
New
11
Increased
54
Reduced
24
Closed
24

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$15.7M
2
INSP icon
Inspire Medical Systems
INSP
+$12.4M
3
AMGN icon
Amgen
AMGN
+$11.3M
4
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$10.7M
5
QGEN icon
Qiagen
QGEN
+$10M

Top Sells

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$13.8M
2
IMGN
Immunogen Inc
IMGN
+$11.4M
3
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$8.68M
4
CRL icon
Charles River Laboratories
CRL
+$8.65M
5
ZBH icon
Zimmer Biomet
ZBH
+$7.97M

Sector Composition

Rank Sector Weight
1 Healthcare 98.72%
2 Industrials 0.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DAWN
26
DELISTED
Day One Biopharmaceuticals
DAWN
$9.14M 1.29%
625,749
+159,341
+34% +$1.93M
MTD icon
27
Mettler-Toledo International
MTD
$28.8B
$9.1M 1.28%
+7,500
New +$8.11M
MNKD icon
28
MannKind Corp
MNKD
$1.24B
$9.09M 1.28%
2,498,624
+429,677
+21% +$1.64M
DCPH
29
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$9.05M 1.27%
561,025
-36,378
-6% -$464K
HUM icon
30
Humana
HUM
$46.7B
$8.28M 1.17%
18,081
-3,230
-15% -$1.59M
CSTL icon
31
Castle Biosciences
CSTL
$960M
$7.71M 1.09%
357,156
+132,564
+59% +$2.33M
CVRX icon
32
CVRx
CVRX
$72.7M
$7.55M 1.06%
240,000
+17,880
+8% +$335K
EWTX icon
33
Edgewise Therapeutics
EWTX
$4.73B
$7.13M 1%
651,625
+178,313
+38% +$1.25M
ARVN icon
34
Arvinas
ARVN
$580M
$6.87M 0.97%
167,001
+62,884
+60% +$1.47M
SILK
35
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$6.69M 0.94%
545,235
+295,894
+119% +$2.78M
VCYT icon
36
Veracyte
VCYT
$3.59B
$6.53M 0.92%
237,316
+11,444
+5% +$276K
HAE icon
37
Haemonetics
HAE
$4.16B
$5.98M 0.84%
69,940
-19,022
-21% -$1.64M
AUGX
38
DELISTED
Augmedix, Inc. Common Stock
AUGX
$5.94M 0.84%
1,015,814
+639,732
+170% +$3.37M
BCYC
39
Bicycle Therapeutics
BCYC
$284M
$5.66M 0.8%
312,889
+190,168
+155% +$3.15M
CGEM icon
40
Cullinan Oncology
CGEM
$1.26B
$5.4M 0.76%
529,877
+91,132
+21% +$807K
IRON icon
41
Disc Medicine
IRON
$3.09B
$5.36M 0.76%
92,871
+40,813
+78% +$2.09M
TMO icon
42
Thermo Fisher Scientific
TMO
$223B
$5.31M 0.75%
10,000
-5,332
-35% -$2.58M
STRO icon
43
Sutro Biopharma
STRO
$353M
$5.16M 0.73%
120,243
+2,026
+2% +$64.3K
BMY icon
44
Bristol-Myers Squibb
BMY
$130B
$5.13M 0.72%
+100,000
New +$5.25M
LNTH icon
45
Lantheus
LNTH
$6.57B
$4.96M 0.7%
80,000
+30,111
+60% +$2.04M
MLTX icon
46
MoonLake Immunotherapeutics
MLTX
$1.47B
$4.95M 0.7%
82,009
+28,716
+54% +$1.48M
PHLT
47
DELISTED
Performant Healthcare Inc
PHLT
$4.94M 0.7%
1,580,865
+281,480
+22% +$737K
RCUS icon
48
Arcus Biosciences
RCUS
$3.69B
$4.73M 0.67%
247,664
+42,555
+21% +$680K
INSM icon
49
Insmed
INSM
$28.9B
$4.67M 0.66%
150,816
+25,816
+21% +$669K
IDYA icon
50
IDEAYA Biosciences
IDYA
$3.56B
$4.63M 0.65%
130,265
-2,436
-2% -$72.7K
1
2
3 4 5

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Parkman Healthcare Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Parkman Healthcare Partners held 113 positions worth $710M, up 30% from $546M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Parkman Healthcare Partners deployed $64.1M of net new capital in Q4 2023, opening 11 new positions and adding to 54 existing holdings. Its largest new stake was Abbott: 156,727 shares worth $17.3M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was Becton Dickinson, an estimated $7.52M trimmed.

  • Parkman Healthcare Partners's largest Q4 2023 buy was Abbott: 156,727 shares worth $17.3M.
  • Parkman Healthcare Partners added most to Inspire Medical Systems in Q4 2023, an estimated $12.4M increase.
  • Parkman Healthcare Partners's biggest Q4 2023 reduction was Becton Dickinson, cutting an estimated $7.52M.
  • Parkman Healthcare Partners fully exited HCA Healthcare in Q4 2023, selling an estimated $13.8M.
  • Parkman Healthcare Partners's ten largest holdings make up 36% of its $710M portfolio in Q4 2023.
  • Parkman Healthcare Partners opened 11 new positions and closed 24 in Q4 2023.
  • Parkman Healthcare Partners's portfolio value rose 30% quarter-over-quarter to $710M.

Based on Parkman Healthcare Partners's 13F filing for Q4 2023, filed 14 Feb 2024.